Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	94-62-2
Formula :	C₉H₁₅NO₅
M.W :	285.34
SMILES Code :	O=C(N1CCCCC1)/C=C/C=C/C2=CC=C(OCO3)C3=C2
Synonyms :	Bioperine; 1-Piperoylpiperidine; N-Piperoylpiperidin
MDL No. :	MFCD00005839
InChI Key :	MXXWOMGUGJBKIW-YPCIICBESA-N
Pubchem ID :	638024

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302
Precautionary Statements:	P280-P305+P351+P338

IEC-6 cells	50 μM, 100 μM	24 h	Piperine did not affect proliferation and migration in IEC-6 cells	Sci Rep. 2020 Jul 15;10(1):11681.
DLD-1 cells	50 μM, 100 μM	24 h	Piperine inhibits proliferation and migration in DLD-1 cells	Sci Rep. 2020 Jul 15;10(1):11681.
N2a cells	2 μM	48 h	Piperine antagonized ER stress by activating MANF expression.	Mol Neurodegener. 2018 Jan 30;13(1):4.
SW480 cells	50 μM, 100 μM	24 h	Piperine inhibits proliferation and migration in SW480 cells	Sci Rep. 2020 Jul 15;10(1):11681.
PC12 cells	2 μM, 10 μM, 50 μM	48 h	Piperine treatment increased MANF protein expression in a dose-dependent manner.	Mol Neurodegener. 2018 Jan 30;13(1):4.
Neonatal rat cardiac fibroblasts	20 μM	24 h	Piperine inhibited the transformation of cardiac fibroblasts to myofibroblasts induced by TGF-β or Ang II in vitro by blocking the activation of the AKT/GSK3β pathway.	EBioMedicine. 2017 Apr;18:179-187.
Mouse adult cardiac fibroblasts	20 μM	24 h	Piperine suppressed the transformation of mouse adult cardiac fibroblasts to myofibroblasts induced by TGF-β through the activation of PPAR-γ receptors.	EBioMedicine. 2017 Apr;18:179-187.
SH-SY5Y cells	25.02 μM	24 h	To study the effect of Piperine on the proliferation of SH-SY5Y cells, results showed that Piperine reached EC50 at 25.02 mM.	Front Aging Neurosci. 2019 Aug 27;11:206.
SH-SY5Y cells	10-25 μM	24 h	To study the synergistic effect of Piperine combined with Curcumin on the proliferation of SH-SY5Y cells, results showed synergistic activity when Piperine at 10-25 mM was combined with Curcumin at 25-50 mM.	Front Aging Neurosci. 2019 Aug 27;11:206.
HSC-3 human oral cancer cells	0, 50, 100, 150, 200 µM	24 h	Piperine significantly reduced the viability of HSC-3 cells, with an IC50 value of 143.99 µM	Int J Mol Sci. 2023 Sep 11;24(18):13949.
HSC-3 human oral cancer cells	0, 100, 150 µM	24 h	Piperine induced apoptosis in HSC-3 cells, with a significant increase in apoptosis rate	Int J Mol Sci. 2023 Sep 11;24(18):13949.
HSC-3 human oral cancer cells	0, 100, 150 µM	24 h	Piperine induced autophagy in HSC-3 cells, with increased acidic vesicular organelles and autophagy marker proteins	Int J Mol Sci. 2023 Sep 11;24(18):13949.
THP-1-derived macrophages	5-100 µM	24 h	Piperine significantly enhances cholesterol efflux (ChE) by upregulating ABCA1 protein expression and inhibits ABCA1 degradation	Mol Nutr Food Res. 2017 Apr;61(4):1500960.
HCT116 cells	50 μM, 100 μM	24 h	Piperine inhibits β-catenin nuclear translocation in HCT116 cells and suppresses cell proliferation	Sci Rep. 2020 Jul 15;10(1):11681.
K562 cells	2.5–300 µM	48, 72, 96 h	Piperine reduced the metabolic activity and viability of K562 cells in a dose-dependent manner, but compared to multidrug-resistant cells (Lucena-1 and FEPS), K562 cells were less sensitive to piperine.	Molecules. 2021 Feb 10;26(4):934.
Lucena-1 cells	2.5–300 µM	48, 72, 96 h	Piperine reduced the metabolic activity and viability of Lucena-1 cells in a dose-dependent manner, and compared to K562 cells, Lucena-1 cells were more sensitive to piperine, suggesting the occurrence of the CS phenomenon.	Molecules. 2021 Feb 10;26(4):934.
FEPS cells	2.5–300 µM	48, 72, 96 h	Piperine reduced the metabolic activity and viability of FEPS cells in a dose-dependent manner, and compared to K562 and Lucena-1 cells, FEPS cells were the most sensitive to piperine, suggesting the occurrence of the CS phenomenon.	Molecules. 2021 Feb 10;26(4):934.

Mice	High-fat diet-induced obesity model	Intragastric administration	20 and 40 mg/kg	Once daily for 10 weeks	Piperine significantly decreased, liver weight, perirenal fat weight, and lowered serum triglycerides, total cholesterol, low-density lipoprotein cholesterol, and glucose levels in HFD-fed mice. Additionally, piperine significantly attenuated fatty liver and modulated hepatic mRNA expressions of SREBP-1c, SREBP2, and HMGCR. In perirenal fat, FAS, C/EBP α, MCP1, and IL-6 expressions were significantly down-regulated by piperine. 16S rRNA sequencing revealed that piperine elevated GM diversity. The relative abundance of Muribaculaceae and Ruminococcaceae were significantly elevated, while Dubosiella and Enterorhabdus genera were suppressed by piperine.	Curr Res Food Sci. 2022 Sep 2;5:1422-1432
C57BL6 mice	High-fat diet-induced gallstone model	Gavage	20 mg/kg	Once daily for 4 weeks	To study the preventive effect of Piperine combined with Curcumin on gallstone formation in mice, the results showed that Piperine could enhance the bioavailability of Curcumin, thereby enhancing its effect on preventing gallstones.	Lipids Health Dis. 2015 Sep 3;14:100
Mice	TBP-105Q KI mice	Oral gavage	10 mg/kg	Daily for two months	Piperine treatment improved motor performances and reduced ER stress in TBP-105Q KI mice.	Mol Neurodegener. 2018 Jan 30;13(1):4.
C57/B6 mice	Pressure overload model	Oral	50 mg/kg	Once daily for 3 weeks	Piperine significantly attenuated cardiac fibrosis induced by pressure overload or isoprenaline (ISO) injection through the activation of PPAR-γ and inhibition of the AKT/GSK3β pathway.	EBioMedicine. 2017 Apr;18:179-187.
Nude mice	HSC-3 xenograft model	Oral	50 mg/kg	Once daily for 4 weeks	Piperine significantly inhibited tumor growth, related to apoptosis and PI3K signaling pathway inhibition	Int J Mol Sci. 2023 Sep 11;24(18):13949.

{[proInfo.proName]}

CAS No.: 94-62-2

{[proInfo.proName]}

CAS No.: 94-62-2

Alternative Products

Product Details of Piperine

Safety of Piperine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT01640197	Healthy	Phase 1	Completed	-	United Kingdom ... More >> Brain performance and nutrition research centre, Northumbria university Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT00065741	HIV Seronegativity	Phase 1	Completed	-	United States, North Carolina ... More >> General Clinical Research Center, Univiversity Of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01640197	-		Completed	-	-
NCT01288859	Healthy	Not Applicable	Completed	-	Italy ... More >> Department of Food Science Portici, Italy, 80055 Less <<
NCT03201835	Healthy Volunteers	Phase 1	Completed	-	Israel ... More >> Clinical Research Center (CRC)- Souraskey Medical center Tel Aviv, Israel Less <<
NCT03206567	Hair Thinning	Not Applicable	Recruiting	December 2017	United States, California ... More >> Ablon Skin Institute & Research Center Recruiting Manhattan Beach, California, United States, 90266 Contact: Shelley Joyce, RN, BSN, CRC 310-727-3376 shelley@abloninstitute.comm Principal Investigator: Glynis Ablon, MD, FAAD Less <<
NCT01729143	Obesity	Not Applicable	Completed	-	United States, North Carolina ... More >> UNC Chapel Hill Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 Less <<
NCT01288859	-		Completed	-	-
NCT00181662	Healthy	Not Applicable	Completed	-	United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03475017	Chronic Kidney Diseases	Phase 3	Enrolling by invitation	December 30, 2021	Brazil ... More >> Denise Mafra Niterói, Rio De Janeiro, Brazil Less <<
NCT03621865	Healthy	Not Applicable	Completed	-	France ... More >> Biofortis Mérieux NutriSciences Saint-Herblain, France, 44800 Less <<
NCT02542449	Obesity	Phase 4	Completed	-	Italy ... More >> IRCCS Istituto Auxologico Italiano Milano, Italy, 20145 Less <<
NCT01331382	Healthy	Not Applicable	Completed	-	United Kingdom ... More >> Brain performance and nutrition research centre, Northumbria university Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT01324089	Focus of the Study: Normal Vol... More >>unteers Less <<	Not Applicable	Completed	-	United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01893424	Pain	Phase 1	Completed	-	Israel ... More >> Hadassah medical organization Jerusalem, Israel Less <<
NCT02598726	Bladder Spasm ... More >> Malignant Neoplasm Pain Urinary Urgency Less <<	Phase 1	Recruiting	March 15, 2021	United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Aminah Jatoi Less <<
NCT00799630	Nutrition Processes	Not Applicable	Completed	-	France ... More >> Service de Physiologie Clinique et de l'Exercice, CHU Saint-Etienne Saint-Etienne, France, 42055 Less <<
NCT01383694	Deglutition Disorders	PHASE1\|PHASE2	COMPLETED	2025-02-12	Hospital de Mataró, Mataró, Ba... More >>rcelona, 08304, Spain Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	3.50mL 0.70mL 0.35mL	17.52mL 3.50mL 1.75mL	35.05mL 7.01mL 3.50mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed